For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
Learn about the optimization of our FirePlex®-HT multiplex assay to deliver and Ultra-HT assay:
For the past five years Bianca has been an integral part of the FirePlex® team at Abcam, where she helped to develop multiplexed miRNA and immunoassays. Originally from Germany, she came to the US in the year 2000 to work on the neurological disease Neurofibromatosis Type II at Massachusetts General Hospital. Instead of moving back to Germany as initially planned, she entered into a PhD program in Cell and Molecular Biology at Boston University, from which she graduated in 2008. Bianca then took on a postdoctoral fellowship at Harvard Medical School to study negative-strand RNA viruses with Dr. Sean Whelan. In 2013, she joined the lively world of the Cambridge Biotech industry, working on exciting projects such as Hepatitis C virus drug development, pathogen diagnostics and most recently high-throughput biomarker screening assays.